Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2017 Filed Jun 14, 2017 18:40 UTC |
KNISS RICHARDDirector
|
Exercise / conversionCommon Stock | 6,000 | $4.13 | $24,780.00 |
DisclosureSEC source: 0001179110-17-009057 · edgar.xml · nonDerivative · entry 2 KNISS RICHARD · CIK 0001142622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 18:40 UTC |
KNISS RICHARDDirector
|
Exercise / conversionCommon Stock | 6,000 | $12.09 | $72,540.00 |
DisclosureSEC source: 0001179110-17-009057 · edgar.xml · nonDerivative · entry 1 KNISS RICHARD · CIK 0001142622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,403 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · derivative · entry 7 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,210 Underlying: Common Stock · 12,403 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options exercised vested on August 7, 2016. The remaining options will vest in three approximately equal annual installments on each of August 7, 2017, 2018 and 2019. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,144 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · derivative · entry 6 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,144 Underlying: Common Stock · 16,144 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options exercised vested in two approximately equal annual installments on August 8, 2015 and 2016. The remaining options will vest in two approximately equal annual installments on each of August 8, 2017 and 2018. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,177 | $0.00 Strike: $20.04 | $0.00 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · derivative · entry 5 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,059 Underlying: Common Stock · 45,177 shares Expires 2023-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options exercised vested in three approximately equal annual installments on August 30, 2014, 2015 and 2016. The remaining options will vest on August 30, 2017. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
SaleCommon Stock | 73,724 | $27.62 | $2,036,500.17 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · nonDerivative · entry 4 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,425 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.60 to $27.67, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 12,403 | $19.82 | $245,827.46 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · nonDerivative · entry 3 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 16,144 | $20.68 | $333,857.92 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 11:53 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 45,177 | $20.04 | $905,347.08 |
DisclosureSEC source: 0001179110-17-008788 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 18:11 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 2,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008299 · edgar.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,756 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on the anniversary of the grant date, May 31, 2018. Read SEC document |
| May 19, 2017 Filed May 22, 2017 15:53 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 3,200 | $26.13 | $83,631.36 |
DisclosureSEC source: 0001179110-17-007679 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,789,051 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.02 to $26.255, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| May 18, 2017 Filed May 19, 2017 17:47 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 35,000 | $26.33 | $921,375.00 |
DisclosureSEC source: 0001179110-17-007578 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,785,851 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.81 to $26.44, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| May 17, 2017 Filed May 19, 2017 17:47 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 38,000 | $26.11 | $992,335.80 |
DisclosureSEC source: 0001179110-17-007578 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,750,851 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.89 to $26.25, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| May 16, 2017 Filed May 17, 2017 16:42 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 1,920 | $25.88 | $49,686.72 |
DisclosureSEC source: 0001179110-17-007373 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,712,851 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.86 to $25.99, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| May 07, 2017 Filed May 9, 2017 19:06 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 1,716 | $25.66 | $44,032.56 |
DisclosureSEC source: 0001179110-17-006885 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,425 Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 14:04 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 4,300 | $23.34 | $100,365.01 |
DisclosureSEC source: 0001179110-17-004893 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,710,931 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.19 to $23.45, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 20:00 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 2,300 | $23.74 | $54,593.49 |
DisclosureSEC source: 0001179110-17-004479 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,706,631 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.69 to $23.765, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC |
Lenggenhager RenePresident, BioSpin Group
|
Exercise / conversionStock option (right to buy) · Derivative | 3,539 | $0.00 Strike: $22.46 | $0.00 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · derivative · entry 3 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620 Underlying: Common Stock · 3,539 shares Expires 2025-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested in four approximately equal annual installments on the anniversary of the grant date, commencing on December 1, 2016. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC |
Lenggenhager RenePresident, BioSpin Group
|
SaleCommon Stock | 3,539 | $23.93 | $84,677.30 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · nonDerivative · entry 2 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,037 Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC |
Lenggenhager RenePresident, BioSpin Group
|
Exercise / conversionCommon Stock | 3,539 | $22.46 | $79,485.94 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · nonDerivative · entry 1 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2017 Filed Feb 23, 2017 12:54 UTC |
MATTACCHIONE ANTHONY LSenior Vice President & CFO
|
Tax withholdingCommon Stock | 1,237 | $24.64 | $30,479.68 |
DisclosureSEC source: 0001179110-17-003008 · edgar.xml · nonDerivative · entry 1 MATTACCHIONE ANTHONY L · CIK 0001248933 · Senior Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,868 F1 · date: The reported transaction involved the withholding of shares of common stock to satisfy the reporting person's tax withholding obligation upon the vesting of restricted stock. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 19:26 UTC |
LAUKIEN JOERG CDirector
|
Exercise / conversionStock Option-right to purchase · Derivative | 3,500 | $0.00 Strike: $12.55 | $0.00 |
DisclosureSEC source: 0001179110-17-002867 · edgar.xml · derivative · entry 2 LAUKIEN JOERG C · CIK 0001133646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2021-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The exercised options vested on September 9, 2016. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 19:26 UTC |
LAUKIEN JOERG CDirector
|
Exercise / conversionCommon Stock | 3,500 | $12.55 | $43,925.00 |
DisclosureSEC source: 0001179110-17-002867 · edgar.xml · nonDerivative · entry 1 LAUKIEN JOERG C · CIK 0001133646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,212,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:00 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000745 · edgar.xml · nonDerivative · entry 4 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,684.018 F2 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:03 UTC |
Fesik Stephen W.Director
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000755 · edgar.xml · nonDerivative · entry 1 Fesik Stephen W. · CIK 0001434744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:03 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000754 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:02 UTC |
VAN INGEN CHRISDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000753 · edgar.xml · nonDerivative · entry 1 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:02 UTC |
Kastner Marc ADirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000752 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:02 UTC |
KNISS RICHARDDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000751 · edgar.xml · nonDerivative · entry 1 KNISS RICHARD · CIK 0001142622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,753 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:02 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000750 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,327 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:01 UTC |
Martin Gilles Gerard JeanDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000749 · edgar.xml · nonDerivative · entry 1 Martin Gilles Gerard Jean · CIK 0001597047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:01 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000748 · edgar.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:01 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000747 · edgar.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:00 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 4,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000746 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,577 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in one installment on January 5, 2018. Read SEC document |
| December 15, 2016 Filed Dec 15, 2016 19:23 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 4,725 | $21.22 | $100,261.67 |
DisclosureSEC source: 0001179110-16-032990 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,704,331 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.12 to $21.27, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 10,000 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 7 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested in approximately equal annual installments on January 7, 2014, 2015 and 2016. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 6 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in approximately equal annual installments on August 13, 2013, 2014 and 2015. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionStock Option (Right to buy) · Derivative | 5,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · derivative · entry 5 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in approximately equal annual installments on June 25, 2013, 2014 and 2015. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
SaleCommon stock | 20,000 | $22.29 | $445,836.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 4 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.131 to $22.60, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionCommon Stock | 10,000 | $16.42 | $164,200.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 3 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionCommon Stock | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 2 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 21:11 UTC |
VAN INGEN CHRISDirector
|
Exercise / conversionCommon Stock | 5,000 | $12.96 | $64,800.00 |
DisclosureSEC source: 0001179110-16-032944 · edgar.xml · nonDerivative · entry 1 VAN INGEN CHRIS · CIK 0001142621 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 14:52 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
PurchaseCommon Stock | 2,124 | $22.90 | $48,631.32 |
DisclosureSEC source: 0001179110-16-032116 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,699,606 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.78 to $22.98, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:29 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 154,284 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0001179110-16-030522 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,284 Underlying: Common Stock · 154,284 shares Expires 2021-10-04 F3 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:29 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 48,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030522 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,697,482 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:29 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantStock Option (Right to Buy) · Derivative | 58,843 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-16-030521 · edgar.xml · derivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,843 Underlying: Common Stock · 58,843 shares Expires 2026-10-04 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:29 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantCommon Stock | 18,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030521 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,141 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:28 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantStock Option (Right to Buy) · Derivative | 39,468 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-16-030520 · edgar.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,468 Underlying: Common Stock · 39,468 shares Expires 2026-10-04 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:28 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantCommon Stock | 12,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030520 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,106 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC |
Lenggenhager RenePresident, BioSpin Group
|
GrantStock Option (Right to Buy) · Derivative | 17,942 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-16-030519 · edgar.xml · derivative · entry 2 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,942 Underlying: Common Stock · 17,942 shares Expires 2026-10-04 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.